Alcoholism Methadone: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge … – MarketWatch (Press Release)

Alcoholism Methadone: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge … – MarketWatch (press release)

Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge
MarketWatch (press release)
Lightlake recently acquired patents that will allow it to widen its product pipeline to address patients with addictions to opioid painkillers, methadone, cocaine and amphetamine. The Company anticipates launching a development program for each of

and more »

Alcoholism Methadone – Google News

Find More Alcoholism Methadone Information…